Cellectis SA (CLLS)

3.22 +0.12 (+3.87%) USD  |  NASDAQ  |  Mar 31, 15:45
More

Cellectis Cash and Short Term Investments (Quarterly) : 208.66M for Dec. 31, 2025

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for CLLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
DBV Technologies SA 194.17M
EDAP TMS SA 20.45M
Akari Therapeutics Plc 2.544M
Biodexa Pharmaceuticals Plc --
Autolus Therapeutics Plc 302.21M